about
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma.Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer.Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lawrence W. Wu
@ast
Lawrence W. Wu
@en
Lawrence W. Wu
@es
Lawrence W. Wu
@nl
Lawrence W. Wu
@sl
type
label
Lawrence W. Wu
@ast
Lawrence W. Wu
@en
Lawrence W. Wu
@es
Lawrence W. Wu
@nl
Lawrence W. Wu
@sl
prefLabel
Lawrence W. Wu
@ast
Lawrence W. Wu
@en
Lawrence W. Wu
@es
Lawrence W. Wu
@nl
Lawrence W. Wu
@sl
P106
P1153
57189458747
P21
P31
P496
0000-0002-8013-1275
P569
2000-01-01T00:00:00Z